Genomic diagnostics company. Could be part of the genomic revolution.
Not so cheap anymore, high risk high reward
Not so cheap anymore, high risk high reward
評論:
add more on breakout
評論:
Long sideways period but still holding and accumulated more of this stock. Adjusted channel.
Some news: "Veracyte Chairman and CEO Bonnie Anderson Receives Prestigious Innovation Award at Biomedical Engineering Society Annual Meeting- The Coulter Foundation’s Wallace H. Coulter Award for Healthcare Innovation Recognizes Excellence and Leadership in Clinical Diagnostic Medicine"
www.businesswire.com...e/20171013005391/en/
Some news: "Veracyte Chairman and CEO Bonnie Anderson Receives Prestigious Innovation Award at Biomedical Engineering Society Annual Meeting- The Coulter Foundation’s Wallace H. Coulter Award for Healthcare Innovation Recognizes Excellence and Leadership in Clinical Diagnostic Medicine"
www.businesswire.com...e/20171013005391/en/
looking to buy breakout 8.50 or support channel trendline